{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T01:50:30Z","timestamp":1795139430527,"version":"4.10.3"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["INV 005318"],"award-info":[{"award-number":["INV 005318"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.vaccine.2025.127189","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T19:41:33Z","timestamp":1746128493000},"page":"127189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Consultation report \u2013 considerations for a regulatory pathway for bivalent Salmonella Typhi\/Paratyphi A vaccines for use in endemic countries"],"prefix":"10.1016","volume":"56","author":[{"given":"Ana Belen","family":"Ibarz-Pavon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Bielsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubina","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cavaleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Crump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Hombach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Kaslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana","family":"Khaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calman A.","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Mehring-LeDoare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdausi","family":"Quadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Wilder-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2025.127189_bb0005","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.01.010401","article-title":"Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010","volume":"2","author":"Buckle","year":"2012","journal-title":"J Glob Health"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127189_bb0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1086\/649541","article-title":"Global trends in typhoid and paratyphoid fever","volume":"50","author":"Crump","year":"2010","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127189_bb0015","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1473-3099(12)70028-2","article-title":"Community-acquired bacterial bloodstream infections in developing countries in south and Southeast Asia: a systematic review","volume":"12","author":"Deen","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127189_bb0020","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1186\/s12879-023-08452-0","article-title":"Associations of water, sanitation, and hygiene with typhoid fever in case-control studies: a systematic review and meta-analysis","volume":"23","author":"Kim","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"Suppl. 6","key":"10.1016\/j.vaccine.2025.127189_bb0025","doi-asserted-by":"crossref","first-page":"S499","DOI":"10.1093\/cid\/ciz705","article-title":"Spatial and temporal patterns of typhoid and paratyphoid fever outbreaks: a worldwide review, 1990\u20132018","volume":"69","author":"Kim","year":"2019","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2025.127189_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9589208","article-title":"Estimating typhoid fever risk associated with lack of access to safe water: a systematic literature review","volume":"2018","author":"Mogasale","year":"2018","journal-title":"J Environ Public Health"},{"key":"10.1016\/j.vaccine.2025.127189_bb0035","series-title":"Molecular Medical Microbiology","first-page":"1275","article-title":"Chapter 71 - Salmonella Typhi and Salmonella Paratyphi A","author":"Sanderson","year":"2015"},{"issue":"892","key":"10.1016\/j.vaccine.2025.127189_bb0040","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/pmj.76.892.80","article-title":"Widal agglutination test \u2212 100 years later: still plagued by controversy","volume":"76","author":"Olopoenia","year":"2000","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.vaccine.2025.127189_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.08.2010.3272","article-title":"Small bowel perforation secondary to enteric Salmonella Paratyphi A infection","volume":"2011","author":"Dunne","year":"2011","journal-title":"BMJ Case Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127189_bb0050","doi-asserted-by":"crossref","first-page":"710","DOI":"10.11150\/kansenshogakuzasshi1970.65.710","article-title":"Clinical research on patients with typhoid and paratyphoid fever (1984-1987). Research Group for Infectious Enteric Diseases, Japan","volume":"65","author":"Matsubara","year":"1991","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.vaccine.2025.127189_bb0055","author":"Institute for Health Metrics and Evaluation [Internet]. [cited"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127189_bb0060","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1016\/S2214-109X(23)00585-5","article-title":"Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990-2019: a modelling study","volume":"12","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127189_bb0065","doi-asserted-by":"crossref","first-page":"e567","DOI":"10.1016\/S2666-5247(22)00093-3","article-title":"The international and intercontinental spread and expansion of antimicrobial-resistant Salmonella Typhi: a genomic epidemiology study","volume":"3","author":"da Silva","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.vaccine.2025.127189_bb0070","doi-asserted-by":"crossref","first-page":"6432580","DOI":"10.1155\/2020\/6432580","article-title":"Extensively drug-resistant (XDR) typhoid: evolution, prevention, and its management","volume":"2020","author":"Akram","year":"2020","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127189_bb0075","doi-asserted-by":"crossref","first-page":"e00105","DOI":"10.1128\/mBio.00105-18","article-title":"Emergence of an extensively drug-resistant Salmonella enterica Serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation Cephalosporins","volume":"9","author":"Klemm","year":"2018","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127189_bb0080","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.4269\/ajtmh.20-0783","article-title":"Continued outbreak of ceftriaxone-resistant Salmonella enterica serotype Typhi across Pakistan and assessment of knowledge and practices among healthcare workers","volume":"104","author":"Nizamuddin","year":"2021","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127189_bb0085","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.1038\/s41467-023-42353-9","article-title":"Assessing the global risk of typhoid outbreaks caused by extensively drug resistant Salmonella Typhi","volume":"14","author":"Walker","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127189_bb0090","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taac086","article-title":"Travel-associated extensively drug-resistant typhoid fever: a case series to inform management in non-endemic regions","volume":"30","author":"Posen","year":"2023","journal-title":"J Travel Med."},{"issue":"Supplement_2","key":"10.1016\/j.vaccine.2025.127189_bb0095","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1093\/cid\/ciaa366","article-title":"Antimicrobial resistance in Typhoidal Salmonella: around the world in 3 days","volume":"71","author":"Saha","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2025.127189_bb0100","first-page":"1038","article-title":"Changing trends in drug resistance among typhoid salmonellae in Rawalpindi, Pakistan","volume":"11","author":"Butt","year":"2005","journal-title":"East Mediterr Health J Rev Sante Mediterr Orient Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127189_bb0105","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3201\/eid0604.000420","article-title":"Drug-resistant Salmonella enterica serotype Paratyphi A in India","volume":"6","author":"Chandel","year":"2000","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127189_bb0110","first-page":"434","article-title":"Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives","volume":"10","author":"Pokharel","year":"2006","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127189_bb0115","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.trstmh.2005.12.011","article-title":"Emergence of Salmonella enterica serotype Paratyphi A as a major cause of enteric fever in Kathmandu","volume":"100","author":"Woods","year":"2006","journal-title":"Nepal Trans R Soc Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127189_bb0120","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3201\/eid0503.990329","article-title":"Paratyphoid fever in India. An emerging problem","volume":"5","author":"Sood","year":"1999","journal-title":"Emerg Infect Dis."},{"issue":"01","key":"10.1016\/j.vaccine.2025.127189_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5799\/jmid.897134","article-title":"Changing pattern of resistance in typhoid fever in an era of antimicrobial resistance: is it time to revisit treatment strategies?","volume":"11","author":"Saxena","year":"2021","journal-title":"J Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127189_bb0130","article-title":"WHO global research priorities for antimicrobial resistance in human health","volume":"12","author":"Bertagnolio","year":"2024","journal-title":"Lancet Microbe"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127189_bb0135","article-title":"From Protection to Prevention: Redefining Vaccines in the Context of Antimicrobial Resistance","volume":"16","author":"Sallam","year":"2024","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127189_bb0140","first-page":"1429","article-title":"The role of adult vaccines as part of antimicrobial stewardship: a scoping review","volume":"12","author":"Williams","year":"2023","journal-title":"Antibiot Basel Switz"},{"key":"10.1016\/j.vaccine.2025.127189_bb0145","author":"World Health Organization"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127189_bb0150","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines: WHO position paper, march 2018 \u2013 recommendations","volume":"37","author":"World Health Organization","year":"2019","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127189_bb0155","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines: WHO position paper, march 2018 \u2013 recommendations","volume":"37","author":"World Health Organization","year":"2019","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2025.127189_bb0160","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella Typhi vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.vaccine.2025.127189_bb0165","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJM200310023491423","article-title":"Persistent efficacy of vi conjugate vaccine against typhoid fever in young children","volume":"349","author":"Mai","year":"2003","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127189_bb0170","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1128\/IAI.72.11.6586-6588.2004","article-title":"Effect of dosage on immunogenicity of a vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children","volume":"72","author":"Canh","year":"2004","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127189_bb0175","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a vi polysaccharide\u2013tetanus toxoid conjugate vaccine (typbar-tcv) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127189_bb0180","unstructured":"Expert Committee on Biological Standardization. Recommendations to assure the quality, safety and efficacy of typhoid conjugate vaccines, Annex 2, TRS No 1030 [Internet]. 2020 Nov [cited 2023 Dec 19] p. 158. Available from: https:\/\/www.who.int\/publications\/m\/item\/tcv71-recommendations."},{"issue":"10111","key":"10.1016\/j.vaccine.2025.127189_bb0185","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet Lond Engl"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127189_bb0190","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1473-3099(18)30804-1","article-title":"Cost-effectiveness of routine and campaign use of typhoid vi-conjugate vaccine in Gavi-eligible countries: a modelling study","volume":"19","author":"Bilcke","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127189_bb0195","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1473-3099(21)00627-7","article-title":"Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study","volume":"22","author":"Birger","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127189_bb0200","author":"Comparison Table of WHO Prequalified Typhoid Conjugate Vaccines (TCV)"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127189_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189100","article-title":"The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi","volume":"12","author":"Arcuri","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127189_bb0210","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa2035916","article-title":"Safety and efficacy of a typhoid conjugate vaccine in Malawian children","volume":"385","author":"Patel","year":"2021","journal-title":"N Engl J Med"},{"issue":"10301","key":"10.1016\/j.vaccine.2025.127189_bb0215","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(21)01124-7","article-title":"Protection by vaccination of children against typhoid fever with a vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial","volume":"398","author":"Qadri","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127189_bb0220","doi-asserted-by":"crossref","first-page":"e1561","DOI":"10.1016\/S2214-109X(21)00346-6","article-title":"Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial","volume":"9","author":"Shakya","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.127189_bb0225","author":"Qadri"},{"key":"10.1016\/j.vaccine.2025.127189_bb0230","article-title":"Longevity of immune response after a single dose of typhoid conjugate vaccine against Salmonella Typhi among children in Hyderabad, Pakistan","volume":"147","author":"Qamar","year":"2024","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127189_bb0235","article-title":"Longevity of immune response after a single dose of typhoid conjugate vaccine against Salmonella Typhi among children in Hyderabad, Pakistan","volume":"147","author":"Qamar","year":"2024","journal-title":"Int J Infect Dis [Internet]"},{"issue":"10425","key":"10.1016\/j.vaccine.2025.127189_bb0240","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(23)02031-7","article-title":"Efficacy of typhoid conjugate vaccine: final analysis of a 4-year, phase 3, randomised controlled trial in Malawian children","volume":"403","author":"Patel","year":"2024","journal-title":"Lancet Lond Engl"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2025.127189_bb0245","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1093\/ofid\/ofad041","article-title":"Salmonella combination vaccines: moving beyond typhoid","volume":"10","author":"MacLennan","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"10436","key":"10.1016\/j.vaccine.2025.127189_bb0250","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/S0140-6736(24)00249-6","article-title":"The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial","volume":"403","author":"Kulkarni","year":"2024","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127189_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-024-00872-6","article-title":"Realising the potential of correlates of protection for vaccine development, licensure and use: short summary","volume":"9","author":"King","year":"2024","journal-title":"Npj Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127189_bb0260","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1377\/hlthaff.24.1.67","article-title":"Surrogate endpoints and FDA\u2019S accelerated approval process","volume":"24","author":"Fleming","year":"2005","journal-title":"Health Aff Proj Hope"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127189_bb0265","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/cix042","article-title":"Evaluation of the clinical and microbiological response to Salmonella Paratyphi A infection in the first paratyphoid human challenge model","volume":"64","author":"Dobinson","year":"2017","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127189_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008783","article-title":"Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model","volume":"14","author":"Gibani","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2025.127189_bb0275","series-title":"Report from hybrid F2F\/virtual meeting [internet]. Geneva, Switzerland","article-title":"WHO\/IVB\u2019s product development for vaccines advisory committee (PDVAC)","author":"Kaslow","year":"2022"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2025.127189_bb0280","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1093\/cid\/ciaa367","volume":"71","author":"Carey","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127189_bb0285","doi-asserted-by":"crossref","first-page":"171","DOI":"10.15585\/mmwr.mm7207a2","article-title":"Typhoid fever surveillance, incidence estimates, and Progress toward typhoid conjugate vaccine introduction \u2014 worldwide, 2018\u20132022","volume":"72","author":"Hancuh","year":"2023","journal-title":"Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127189_bb0290","doi-asserted-by":"crossref","first-page":"e599","DOI":"10.1016\/S2214-109X(24)00007-X","article-title":"Incidence of typhoid fever in Burkina Faso, Democratic Republic of the Congo, Ethiopia, Ghana, Madagascar, and Nigeria (the severe typhoid in Africa programme): a population-based study","volume":"12","author":"Marks","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127189_bb0295","doi-asserted-by":"crossref","first-page":"e1688","DOI":"10.1016\/S2214-109X(21)00370-3","article-title":"Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study","volume":"9","author":"Meiring","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127189_bb0300","doi-asserted-by":"crossref","first-page":"e978","DOI":"10.1016\/S2214-109X(22)00119-X","article-title":"Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the surveillance for enteric fever in Asia project","volume":"10","author":"Garrett","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127189_bb0305","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.127189_bb0310","article-title":"PDVAC executive summary 2019: 6th annual meeting [internet]","author":"Immunization","year":"2019","journal-title":"World Health Organ Immun Vaccines Biol"},{"key":"10.1016\/j.vaccine.2025.127189_bb0315","author":"Martin"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127189_bb0320","first-page":"164","article-title":"Culture of Salmonella Typhi and Salmonella Paratyphi from blood and bone marrow in suspected typhoid fever","volume":"47","author":"Gasem","year":"1995","journal-title":"Trop Geogr Med"},{"issue":"7918","key":"10.1016\/j.vaccine.2025.127189_bb0325","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(75)92194-7","article-title":"Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella Typhi in typhoid fever","volume":"1","author":"Gilman","year":"1975","journal-title":"Lancet Lond Engl"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127189_bb0330","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/0035-9203(79)90020-8","article-title":"Diagnostic value of bone marrow culture in typhoid fever","volume":"73","author":"Guerra-Caceres","year":"1979","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127189_bb0335","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/jcp.44.3.258","article-title":"Comparative yield of Salmonella Typhi from blood and bone marrow cultures in patients with fever of unknown origin","volume":"44","author":"Farooqui","year":"1991","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127189_bb0340","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00006454-198509000-00011","article-title":"Efficacy of bone marrow, blood, stool and duodenal contents cultures for bacteriologic confirmation of typhoid fever in children","volume":"4","author":"Vallenas","year":"1985","journal-title":"Pediatr Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2025.127189_bb0345","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1093\/cid\/ciaa503","article-title":"The current status of enteric fever diagnostics and implications for disease control","volume":"71","author":"Baker","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127189_bb0350","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2334-10-45","article-title":"Searching for the elusive typhoid diagnostic","volume":"5","author":"Baker","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127189_bb0355","author":"ISRCTN Registry"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127189_bb0360","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068966","volume":"13","author":"McCann","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2025.127189_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1457785","article-title":"The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines","volume":"15","author":"McCann","year":"2024","journal-title":"Front Immun"},{"issue":"26","key":"10.1016\/j.vaccine.2025.127189_bb0370","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.vaccine.2016.03.106","article-title":"Status of paratyphoid fever vaccine research and development","volume":"34","author":"Martin","year":"2016","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127189_bb0375","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3390\/vaccines11111671","article-title":"Induction of broad immunity against invasive Salmonella disease by a Quadrivalent combination Salmonella MAPS vaccine targeting Salmonella Enterica Serovars Typhimurium, Enteritidis, Typhi, and Paratyphi A","volume":"11","author":"Boerth","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.127189_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1457785","article-title":"The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines","volume":"15","author":"McCann","year":"2024","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127189_bb0385","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.3389\/fimmu.2019.02582","article-title":"IgA and IgG1 specific to vi polysaccharide of Salmonella Typhi correlate with protection status in a typhoid fever controlled human infection model","volume":"1","author":"Dahora","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127189_bb0390","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201116","article-title":"Vi-specific serological correlates of protection for typhoid fever","volume":"218","author":"Jin","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2025.127189_bb0395","author":"Directorate General of Health Services. Ministry of health & Familiy welfare. Goverment of India"},{"key":"10.1016\/j.vaccine.2025.127189_bb0400","author":"European Medicines Agency. Commitee for Medicinal Prodcuts for Human Use"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127189_bb0405","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0022-3859.173187","article-title":"The clinical development process for a novel preventive vaccine: an overview","volume":"62","author":"Singh","year":"2016","journal-title":"J Postgrad Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25004864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25004864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:46:39Z","timestamp":1786221999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25004864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":81,"alternative-id":["S0264410X25004864"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127189","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consultation report \u2013 considerations for a regulatory pathway for bivalent Salmonella Typhi\/Paratyphi A vaccines for use in endemic countries","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127189"}}